Synopsys
SNPS
$405.98
+1.29%
Synopsys Inc. is a leading provider of electronic design automation (EDA) software and intellectual property (IP) products, essential for designing and verifying complex semiconductor chips. The company holds a dominant market position alongside Cadence, benefiting from the convergence of semiconductor and systems companies investing in custom silicon for AI and other advanced applications. Currently, investor attention is focused on Synopsys' integration of Ansys, which has boosted reported revenue but raised questions about organic growth, while the stock has declined sharply despite earnings beats, reflecting concerns about valuation and near-term momentum.…
SNPS
Synopsys
$405.98
Related headlines
Investment Opinion: Should I buy SNPS Today?
Rating: Hold. The consensus recommendation is 'Buy' with an average target price of $564.43, implying a 45.2% upside, but the stock is in a downtrend and faces significant integration risks. The thesis is that while the long-term fundamentals are strong, the near-term earnings drag from the Ansys acquisition and weak organic growth warrant caution.
Sign up to view all
SNPS 12-Month Price Forecast
The AI assessment is neutral, reflecting a balance between the company's strong market position and the near-term financial strain from the Ansys acquisition. The forward valuation is attractive, but the earnings collapse and weak organic growth create uncertainty. If the company demonstrates margin recovery and organic growth in the next two quarters, the stance would upgrade to bullish. Conversely, further deterioration in margins or a guidance cut would lead to a bearish stance.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Synopsys's 12-month outlook, with a consensus price target around $564.43 and implied upside of +39.0% versus the current price.
Average Target
$564.43
0 analysts
Implied Upside
+39.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$415 - $650
Analyst target range
Synopsys is covered by 25 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.71 (where 1 is Strong Buy and 5 is Sell). The average price target is $564.43, implying a substantial 45.2% upside from the current price of $388.76. The distribution of ratings includes 10 recent actions, with firms like Piper Sandler upgrading to Overweight in June 2026, while others like BNP Paribas maintain Underperform, indicating a split sentiment. The target price range is wide, from a low of $414.77 to a high of $650.00, reflecting high uncertainty about the company's growth trajectory and integration success. The low target suggests that even the most bearish analyst sees some upside, while the high target implies a return to previous highs, assuming strong execution and margin recovery. Recent ratings actions show a mix of upgrades and reiterations, with no major downgrades, suggesting that analysts remain cautiously optimistic despite the stock's decline.
Bulls vs Bears: SNPS Investment Factors
The bull case rests on Synopsys' dominant EDA franchise, strong gross margins, and the potential for earnings recovery as Ansys integration synergies materialize, supported by a consensus Buy rating and a forward P/E below industry average. The bear case highlights the dramatic earnings collapse, weak organic growth, and a stock in a steep downtrend, with the trailing P/E still at a premium. Currently, the bearish evidence is stronger in the near term, given the stock's technical weakness and margin compression, but the long-term bull thesis hinges on whether the company can restore profitability and demonstrate organic growth. The most critical tension is whether the Ansys acquisition will ultimately enhance or destroy shareholder value, as the market is skeptical about the integration's benefits.
Bullish
- Dominant EDA franchise with secular AI tailwinds: Synopsys holds a leading position in electronic design automation (EDA), essential for designing complex chips. The convergence of semiconductor and systems companies investing in custom silicon for AI expands its addressable market, with revenue growing 41.9% YoY in Q2 2026, largely from the Ansys acquisition.
- Strong gross margin of 72.3%: Gross margin remained robust at 72.3% in Q2 2026, reflecting the high-value nature of its software and IP. This provides a solid foundation for operating leverage as integration costs subside.
- Analyst consensus Buy with 45% upside: The average analyst price target is $564.43, implying a 45.2% upside from the current price of $388.76. With a mean recommendation score of 1.71 (Strong Buy), analysts see significant recovery potential.
- Forward P/E below industry average: The forward P/E of 22.5x is below the software industry average of ~30x, suggesting the market is pricing in a normalization of earnings. If EPS estimates are met, the stock could be undervalued on a forward basis.
Bearish
- Sharp earnings collapse post-acquisition: Net income plunged to $17.1 million in Q2 2026 from $448.7 million in Q4 2025, a 96% drop. Operating margin fell to 10.4% from 23.4% a year earlier, reflecting heavy integration costs and interest expenses.
- Weak organic growth masked by Ansys: Reported revenue growth of 41.9% is inflated by the Ansys acquisition. Organic growth appears weaker, with Q2 2026 revenue of $2.276 billion down 5.5% sequentially from Q1 2026's $2.409 billion, raising concerns about underlying demand.
- Stock in a severe downtrend: SNPS is down 38.6% over the past year, underperforming the S&P 500 by 56.8 percentage points. The stock trades just 6.2% above its 52-week low of $366.00, indicating persistent selling pressure.
- High trailing P/E of 55.8x: Despite the forward P/E being reasonable, the trailing P/E of 55.8x is 86% above the industry average of 30x. This premium is hard to justify given the current earnings slump, making the stock vulnerable to multiple compression.
SNPS Technical Analysis
Synopsys is in a pronounced downtrend, with the stock price at $388.76 as of July 31, 2026, down 38.6% over the past year. The current price sits just 6.2% above its 52-week low of $366.00, while being 38.9% below its 52-week high of $636.61, indicating that the stock is trading near the bottom of its range, which often signals either a value opportunity or a falling knife. The 1-year price change of -38.6% contrasts sharply with the S&P 500's +18.2% gain, showing significant underperformance and a clear bearish trend.
Beta
1.21
1.21x market volatility
Max Drawdown
-42.3%
Largest decline past year
52-Week Range
$366-$633
Price range past year
Annual Return
-35.1%
Cumulative gain past year
| Period | SNPS Return | S&P 500 |
|---|---|---|
| 1m | -7.0% | +2.8% |
| 3m | -21.4% | +4.2% |
| 6m | -4.9% | +11.3% |
| 1y | -35.1% | +21.5% |
| ytd | -15.5% | +12.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SNPS Fundamental Analysis
Synopsys reported revenue of $2.276 billion for the quarter ending April 30, 2026, representing a 41.9% year-over-year increase, driven largely by the Ansys acquisition. However, organic growth appears weaker, as the company's Q1 2026 revenue of $2.409 billion was higher than Q2, suggesting a sequential decline of 5.5%. The revenue mix includes $945.6 million from license and maintenance, $546.3 million from license, and $784.1 million from technology services, with the latter likely benefiting from Ansys integration. Net income for Q2 2026 was a mere $17.1 million, a dramatic drop from $448.7 million in Q4 2025, reflecting elevated operating expenses and interest costs from the acquisition. Gross margin remains strong at 72.3%, but operating margin fell to 10.4% in Q2 2026 from 23.4% in Q2 2025, indicating margin compression due to integration costs and higher R&D spending. The company's balance sheet shows a debt-to-equity ratio of 0.50, which is manageable but elevated from historical levels, and free cash flow for the trailing twelve months was $2.676 billion, providing ample coverage for interest expenses. ROE stands at 4.7%, down from 12.4% in Q4 2024, reflecting lower net income and a larger equity base post-acquisition.
Quarterly Revenue
$2.3B
2026-04
Revenue YoY Growth
+41.9%
YoY Comparison
Gross Margin
72.3%
Latest Quarter
Free Cash Flow
$2.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SNPS Overvalued?
Given that Synopsys has positive net income, the trailing P/E ratio is the primary valuation metric, currently at 55.8x, while the forward P/E is 22.5x, indicating that the market expects significant earnings growth in the next year. The gap between trailing and forward P/E suggests that analysts anticipate a substantial recovery in profitability as Ansys integration synergies materialize. Compared to the software industry average P/E of approximately 30x, Synopsys trades at a 86% premium on a trailing basis, but the forward P/E of 22.5x is actually below the industry average, implying that the market is pricing in a normalization of earnings. Historically, Synopsys' P/E has ranged from 17.7x (Q4 2024) to 1340.6x (Q2 2026), with the current 55.8x sitting near the middle of that range, though the extreme high was due to depressed earnings. The PS ratio of 10.3x is above the 5-year average of around 45x, but this is skewed by the acquisition, and the EV/Sales of 9.2x is more reasonable for a company with Synopsys' growth prospects.
PE
55.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 37x~73x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are elevated due to the Ansys acquisition. Net income fell to just $17.1 million in Q2 2026 from $448.7 million in Q4 2025, a 96% drop, while operating margin contracted to 10.4% from 23.4% a year earlier. The debt-to-equity ratio rose to 0.50, and interest expenses of $133.4 million in Q2 2026 are a significant drag on profitability. Although free cash flow of $2.676 billion covers interest costs, the company's ROE has fallen to 4.7%, indicating weak returns on the expanded equity base. Revenue concentration in the semiconductor industry also poses a risk if chip design spending slows.